@jamesp
The OpenAI of Longevity...
Before OpenAI launched ChatGPT, Sam Altman invested all his networth in two companies.
One of them, Retro Biosciences, is a longevity company
He was their sole investor, putting $180m in. Apparently talks to the CEO every weekend. They aim for therapeutics in patients by end of decade